Highland Capital Wants PDL BioPharma (PDLI) To Hire A New Advisor For Sale Process
Tweet Send to a Friend
In an amended 13D filing today on PDL BioPharma (Nasdaq: PDLI) today, 7% holder Highland Capital Management, L.P. disclosed a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
